Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania

被引:103
作者
Haimeur, A
Guimond, C
Pilote, S
Mukhopadhyay, R
Rosen, BP
Poulin, R
Ouellette, M
机构
[1] Univ Laval, Fac Med, Ctr Rech Infectiol, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, CHUL, Ctr Rech, Quebec City, PQ G1V 4G2, Canada
[3] Univ Laval, Fac Med, Dept Microbiol, Quebec City, PQ G1V 4G2, Canada
[4] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA
关键词
D O I
10.1046/j.1365-2958.1999.01634.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The levels of trypanothione, a glutathione-spermidine conjugate, are increased in the protozoan parasite Leishmania selected for resistance to the heavy metal arsenite. The levels of putrescine and spermidine were increased in resistant mutants. This increase is mediated by overexpression of ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis. Gene overexpression is generally mediated by gene amplification in Leishmania but, here, the mRNA and the enzymatic activity of ODC are increased without gene amplification. This RNA overexpression is stable when cells are grown in the absence of the drug and does not result from gene rearrangements or from an increased rate of RNA synthesis. Transient transfections suggest that mutations in the revertant cells contribute to these elevated levels of RNA. Stable transfection of the ODC gene increases the level of trypanothione, which can contribute to arsenite resistance. In addition to ODC overexpression, the gene for the ABC transporter PGPA is amplified in the mutants. The co-transfection of the ODC and PGPA genes confers resistance in a synergistic fashion in partial revertants, also suggesting that PGPA recognizes metals conjugated to trypanothione.
引用
收藏
页码:726 / 735
页数:10
相关论文
共 59 条
[1]  
[Anonymous], 1989, SYNTHETIC OLIGONUCLE
[2]   ESTIMATION OF POPULATION AT RISK OF INFECTION AND NUMBER OF CASES OF LEISHMANIASIS [J].
ASHFORD, RW ;
DESJEUX, P ;
DERAADT, P .
PARASITOLOGY TODAY, 1992, 8 (03) :104-105
[3]   Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].
Berman, JD .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703
[4]   GENE AMPLIFICATION IN LEISHMANIA [J].
BEVERLEY, SM .
ANNUAL REVIEW OF MICROBIOLOGY, 1991, 45 :417-444
[5]  
BORST P, 1995, ANNU REV MICROBIOL, V49, P427, DOI 10.1146/annurev.mi.49.100195.002235
[6]  
Brown JL, 1996, CANCER LETT, V98, P227
[7]  
CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427
[8]   Effects of cationic diamidines on polyamine content and uptake on Leishmania infantum in in vitro cultures [J].
Calonge, M ;
Johnson, R ;
BalanaFouce, R ;
Ordonez, D .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (06) :835-841
[9]   The developmental expression of Leishmania donovani A2 amastigote-specific genes is post-transcriptionally mediated and involves elements located in the 3'-untranslated region [J].
Charest, H ;
Zhang, WW ;
Matlashewski, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (29) :17081-17090
[10]   Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells [J].
Chen, ZS ;
Mutoh, M ;
Sumizawa, T ;
Furukawa, T ;
Haraguchi, M ;
Tani, A ;
Akiyama, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (03) :586-590